triazolam has been researched along with Carbon Monoxide Poisoning in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Carbon Monoxide Poisoning: Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of flumazenil, a benzodiazepine antagonist, was studied in two patients with coma of unknown etiology." | 9.06 | The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. ( Burkhart, KK; Kulig, KW, 1990) |
| "The use of flumazenil, a benzodiazepine antagonist, was studied in two patients with coma of unknown etiology." | 5.06 | The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. ( Burkhart, KK; Kulig, KW, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burkhart, KK | 1 |
| Kulig, KW | 1 |
1 trial available for triazolam and Carbon Monoxide Poisoning
| Article | Year |
|---|---|
The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology.
Topics: Adult; Alprazolam; Carbon Monoxide Poisoning; Clinical Trials as Topic; Coma; Double-Blind Method; D | 1990 |